Sabby Management’s Briacell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116K | Buy |
+3,953
| New | +$116K | 0.21% | 23 |
|
|
2024
Q2 | – | Sell |
-228
| Closed | -$97.9K | – | 30 |
|
|
2024
Q1 | $97.9K | Buy |
+228
| New | +$97.9K | 0.06% | 26 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 51 |
|
|
2023
Q1 | – | Sell |
-79
| Closed | -$52K | – | 78 |
|
|
2022
Q4 | $52K | Sell |
79
-548
| -87% | -$361K | 0.05% | 69 |
|
|
2022
Q3 | $528K | Buy |
627
+243
| +63% | +$205K | 0.67% | 28 |
|
|
2022
Q2 | $332K | Buy |
384
+184
| +92% | +$159K | 0.23% | 33 |
|
|
2022
Q1 | $304K | Buy |
+200
| New | +$304K | 0.05% | 52 |
|
|
2021
Q3 | – | Sell |
-1,307
| Closed | -$1.05M | – | 99 |
|
|
2021
Q2 | $1.05M | Buy |
1,307
+239
| +22% | +$191K | 0.15% | 40 |
|
|
2021
Q1 | $618K | Buy |
+1,068
| New | +$618K | 0.12% | 50 |
|